#news #biotech Lilly’s tirzepatide beats Novo’s semaglutide in diabetes phase 3, but another study muddies picture

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Lilly’s tirzepatide beats Novo’s semaglutide in diabetes phase 3, but another study muddies picture .Lilly’s tirzepatide beats Novo’s semaglutide in diabetes phase 3, but another study muddies picture
ntaylor
Thu, 03/04/2021 – 07:47

from FierceBiotech: Biotech https://ift.tt/3ri3vDx